Literature DB >> 19682026

A new rapid micromethod for the assay of phenobarbital from dried blood spots by LC-tandem mass spectrometry.

Giancarlo la Marca1, Sabrina Malvagia, Luca Filippi, Francesca Luceri, Gloriano Moneti, Renzo Guerrini.   

Abstract

Advantages of dried blood spot include low invasiveness, ease and low cost of sample collection, transport, and storage. We used tandem mass spectrometry (LC-MS/MS) to determine phenobarbital levels on dried blood spot specimens and compared this methodology to commercially available particle enhanced turbidimetric inhibition immunoassay (PETINIA) in plasma/serum samples. The calibration curve in matrix using D(5)-phenobarbital as internal standard was linear in the phenobarbital concentration range of 1-100 mg/L (correlation coefficient 0.9996). The coefficients of variation in blood spots ranged 2.29-6.71% and the accuracy ranged 96.54-103.87%. There were no significant differences between the concentrations measured using PETINA and LC-MS/MS (both had similar precision and accuracy) however, LC-MS/MS allows at least 1.5 times higher throughput of phenobarbital analysis and additionally offers ease of sample collection which is particularly important for newborns or small infants.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19682026     DOI: 10.1111/j.1528-1167.2009.02204.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  6 in total

1.  Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491.

Authors:  Luca Filippi; Giacomo Cavallaro; Patrizio Fiorini; Marta Daniotti; Valentina Benedetti; Gloria Cristofori; Gabriella Araimo; Luca Ramenghi; Agostino La Torre; Pina Fortunato; Liliana Pollazzi; Giancarlo la Marca; Sabrina Malvagia; Paola Bagnoli; Chiara Ristori; Massimo Dal Monte; Anna Rita Bilia; Benedetta Isacchi; Sandra Furlanetto; Francesca Tinelli; Giovanni Cioni; Gianpaolo Donzelli; Silvia Osnaghi; Fabio Mosca
Journal:  BMC Pediatr       Date:  2010-11-18       Impact factor: 2.125

Review 2.  Therapeutic drug monitoring by dried blood spot: progress to date and future directions.

Authors:  Abraham J Wilhelm; Jeroen C G den Burger; Eleonora L Swart
Journal:  Clin Pharmacokinet       Date:  2014-11       Impact factor: 6.447

3.  Advantages and Challenges of Dried Blood Spot Analysis by Mass Spectrometry Across the Total Testing Process.

Authors:  Rosita Zakaria; Katrina J Allen; Jennifer J Koplin; Peter Roche; Ronda F Greaves
Journal:  EJIFCC       Date:  2016-12-01

Review 4.  The Use of Dried Blood Spots for the Quantification of Antihypertensive Drugs.

Authors:  Alexander Chernonosov
Journal:  Int J Anal Chem       Date:  2018-08-01       Impact factor: 1.885

5.  Determination of Antidepressants and Antipsychotics in Dried Blood Spots (DBSs) Collected from Post-Mortem Samples and Evaluation of the Stability over a Three-Month Period.

Authors:  Matteo Moretti; Francesca Freni; Beatrice Valentini; Claudia Vignali; Angelo Groppi; Silvia Damiana Visonà; Antonio Marco Maria Osculati; Luca Morini
Journal:  Molecules       Date:  2019-10-09       Impact factor: 4.411

6.  Is Hepatitis Delta infections important in Brazil?

Authors:  Maira Ferreira Cicero; Nathalia Mantovani Pena; Luiz Claudio Santana; Rafael Arnold; Rafael Gonçalves Azevedo; Élcio de Souza Leal; Ricardo Sobhie Diaz; Shirley Vasconcelos Komninakis
Journal:  BMC Infect Dis       Date:  2016-09-29       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.